From Anomaly Detection to Human–AI Collaboration: Explainable Unsupervised Discovery of Atypical Clinical Profiles for Clinician-Guided Decision Support in Heart Failure

Artificial intelligence (AI) has demonstrated promising capabilities for discovering complex patterns in clinical data; however, meaningful clinical use requires more than autonomous model output. Clinicians must be able to inspect, contextualize, and challenge AI-generated findings before those findings influence patient assessment. This study therefore reframes explainable unsupervised anomaly detection as a human–AI collaboration framework for identifying and interpreting atypical clinical profiles among patients with heart failure. The AI component uses Isolation Forest to discover unusual multidimensional patient profiles without incorporating mortality outcomes during model development, while SHAP-based explanations expose the clinical variables contributing to global and patient-level anomaly patterns. The framework was evaluated using the Heart Failure Clinical Records dataset consisting of 299 patients and 12 clinical variables. The model identified 45 patients (15.1%) as anomalous profiles and 254 patients (84.9%) as non-anomalous profiles. The anomalous subgroup demonstrated a mortality rate of 60.0%, compared with 27.2% among non-anomalous patients, and showed a mortality enrichment ratio of approximately 1.87 relative to the overall cohort. Clinical profile analysis revealed substantially higher creatine phosphokinase and serum creatinine levels among anomalous patients, with fold changes of 2.99 and 1.76, respectively. SHAP analysis identified high blood pressure, sex, creatine phosphokinase, smoking status, ejection fraction, platelet count, age, and serum creatinine as important contributors to anomaly formation. A local explanation further demonstrated an atypical case characterized by preserved ejection fraction together with severe biochemical abnormalities. Within the proposed collaborative workflow, these AI outputs are treated as interpretable evidence for clinician review rather than autonomous diagnoses: the AI highlights unusual patterns and explains them, while the clinician contributes patient context, medical knowledge, and final judgment. Because this retrospective study did not include a clinician user study, the results demonstrate the technical readiness of the framework for human–AI collaboration rather than improved team performance. Future prospective evaluation should examine how clinicians use, verify, and override explainable anomaly findings in real clinical workflows.

Authors

Institutions

Publication Details

Journal
International Journal for Applied Information Management
Published
2026-11-17
DOI
https://doi.org/10.47738/ijaim.v6i4.137
Primary Topic
Artificial Intelligence in Healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

From Anomaly Detection to Human–AI Collaboration: Explainable Unsupervised Discovery of Atypical Clinical Profiles for Clinician-Guided Decision Support in Heart Failure

R. Pugalenthi
2 links
International Journal for Applied Information Management
Artificial Intelligence in Healthcare
article

From Anomaly Detection to Human–AI Collaboration: Explainable Unsupervised Discovery of Atypical Clinical Profiles for Clinician-Guided Decision Support in Heart Failure

R. Pugalenthi
article en

Abstract

Artificial intelligence (AI) has demonstrated promising capabilities for discovering complex patterns in clinical data; however, meaningful clinical use requires more than autonomous model output. Clinicians must be able to inspect, contextualize, and challenge AI-generated findings before those findings influence patient assessment. This study therefore reframes explainable unsupervised anomaly detection as a human–AI collaboration framework for identifying and interpreting atypical clinical profiles among patients with heart failure. The AI component uses Isolation Forest to discover unusual multidimensional patient profiles without incorporating mortality outcomes during model development, while SHAP-based explanations expose the clinical variables contributing to global and patient-level anomaly patterns. The framework was evaluated using the Heart Failure Clinical Records dataset consisting of 299 patients and 12 clinical variables. The model identified 45 patients (15.1%) as anomalous profiles and 254 patients (84.9%) as non-anomalous profiles. The anomalous subgroup demonstrated a mortality rate of 60.0%, compared with 27.2% among non-anomalous patients, and showed a mortality enrichment ratio of approximately 1.87 relative to the overall cohort. Clinical profile analysis revealed substantially higher creatine phosphokinase and serum creatinine levels among anomalous patients, with fold changes of 2.99 and 1.76, respectively. SHAP analysis identified high blood pressure, sex, creatine phosphokinase, smoking status, ejection fraction, platelet count, age, and serum creatinine as important contributors to anomaly formation. A local explanation further demonstrated an atypical case characterized by preserved ejection fraction together with severe biochemical abnormalities. Within the proposed collaborative workflow, these AI outputs are treated as interpretable evidence for clinician review rather than autonomous diagnoses: the AI highlights unusual patterns and explains them, while the clinician contributes patient context, medical knowledge, and final judgment. Because this retrospective study did not include a clinician user study, the results demonstrate the technical readiness of the framework for human–AI collaboration rather than improved team performance. Future prospective evaluation should examine how clinicians use, verify, and override explainable anomaly findings in real clinical workflows.

International Journal for Applied Information ManagementVol. 6(4)
Saveetha University (IN)
Good health and well-being
Artificial Intelligence in Healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon